Celltrion's rapid COVID tests hit with 2nd Class I recall in

Celltrion’s range of COVID-19 diagnostic kits have once again fallen under the FDA’s microscope, just weeks after the regulator cracked down on sales of a version of the company's rapid antigen tes

Related Keywords

, Celltrion , Classi Recall , Fda , Covid 19 , Diagnostic Tests , Coronavirus , Diagnostics , Fierce Biotech Homepage , Medtech ,